Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 2Tuberous Sclerosis 1Tourette Syndrome 1Tic Disorders 1Pain 1Neurodevelopmental Disorders 1Mental Disorders 1Fragile X Syndrome 1DiGeorge Syndrome 1Depressive Disorder 1Depression 1Caregiver Burden 1Autistic Disorder 1Autism Spectrum Disorder 1Attention Deficit Disorder with Hyperactivity 1Anxiety Disorders 122q11 Deletion Syndrome 1

Interventions

Everolimus 5ziprasidone 1Zolpidem 1Warfarin 1Vecuronium Bromide 1Vancomycin 1Tranexamic Acid 1Tobramycin 1Spironolactone 1Sirolimus 1Sevelamer 1Sertraline 1Selective Serotonin Reuptake Inhibitors 1Rocuronium 1Piperacillin, Tazobactam Drug Combination 1Pentobarbital 1Oxycodone 1Nifedipine 1Nafcillin 1Molindone 1Methylprednisolone 1Medical Marijuana 1Magnetoencephalography 1Lurasidone Hydrochloride 1Labetalol 1Haloperidol 1Fosfomycin 1Clozapine 1Ciprofloxacin 1Cidofovir 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Autistic Disorder × Selective Serotonin Reuptake Inhibitors × Clear all
NCT06081348 2025-07-16

CALM

Holland Bloorview Kids Rehabilitation Hospital

Phase 2 Recruiting
130 enrolled

Autism Spectrum Disorder, Anxiety Disorders, Attention Deficit Disorder with Hyperactivity, Autistic Disorder, DiGeorge Syndrome, Fragile X Syndrome, Tourette Syndrome, Tic Disorders, Tuberous Sclerosis, 22q11 Deletion Syndrome, Neurodevelopmental Disorders

Data powered by HemOnc (CC BY 4.0) Colophon âš¡